Exicure, Inc. Common Stock XCUR
$1.60
+1.91%
at last close
Market Cap$10.20 million
P/E Ratio—
Div Yield—
Volume17.7K
52-Week Range
$1.43$9.50
Key Stats
- Today's Range
- $1.55 – $1.65
- 50-Day Range
- $1.43 – $3.45
- 52-Week Range
- $1.43 – $9.50
- Volume
- 18K shs
- Average Volume
- 811K shs
- Market Cap
- $10.20 million
- P/E Ratio
- —
- Dividend Yield
- —
Short Interest
- Short Interest
- 0.01%
- Days to Cover
- 1.00
About Exicure, Inc. Common Stock
Exicure Inc is a clinical-stage biotechnology company focused on developing treatments for blood-related diseases, with an emphasis on small-molecule therapies that have the potential to benefit a broad range of patients. The company acquired GPCR Therapeutics USA and secured a license for GPC-100 (Burixafor), a clinical-stage small-molecule compound that inhibits the chemokine receptor CXCR4. GPC-100 has demonstrated the ability to effectively mobilize various cell types, including hematopoietic stem cells and lymphocytes, highlighting its broad therapeutic potential across multiple indications.
Related Stocks
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.